摘要
对术后常规治疗的45例乳腺癌患者加用免疫调节剂卡介菌多糖核酸（斯奇康）治疗（A组），并与25例常规治疗者（B组）对照，以观察斯奇康对细胞免疫功能的影响。结果显示：A组T淋巴细胞亚群CD4/CD8比值升高，B组CD4/CD8比值无明显改变。提示斯奇康能激活T淋巴细胞亚群，改善机体免疫功能，表明其可作为乳腺癌患者较好的辅助治疗手段。
In order to observe the effect of BCG - PSN on cellular innnune, fourty - five cases of breast cancer after surgery were treated with BCG-PSN in addition to rouhne treatment (Group A). They were compared with 25 eases who receive rouhne trcabent alone (Group B). The result shows the ratio of lympho cyte subgroup CD4/CD8 gets higher in group A and remainds in group B. It suggests that BCG - PSN is able to activeae T lmphocyte suhgroup and improne cellular immne Therefore, BCG - PSN may be used a good auxilliary therapy for breast cancer patient.
出处
《肿瘤防治研究》
CAS
CSCD
北大核心
1999年第6期434-434,436,共2页
Cancer Research on Prevention and Treatment
